<DOC>
	<DOCNO>NCT01102400</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability MEDI-575 Japanese patient advance solid tumor ( dose escalation part ) hepatocellular carcinoma ( expansion part ) .</brief_summary>
	<brief_title>A Study MEDI-575 Patients With Advanced Solid Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Having advance solid malignancy curative standard therapy exist Karnofsky performance status â‰¥60 Patients must histological confirmed diagnosis HCC standard therapy available ( expansion part ) Inadequate bone marrow reserve organ function Major surgery within 4 week minor surgery within 2 week prior receipt MEDI575 . Patients must unhealed wound unhealed fracture History allergy reaction component MEDI575 and/or monoclonal antibody</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>cancer</keyword>
	<keyword>tumor</keyword>
	<keyword>hepatocellular carcinoma</keyword>
</DOC>